Efficacy and safety of pravastatin in patients with primary hypercholesterolemia
- 1 December 1990
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 85 (2-3) , 219-227
- https://doi.org/10.1016/0021-9150(90)90114-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pravastatin Sodium: A Novel Cholesterol‐Lowering Agent that Inhibits HMG‐CoA ReductaseCardiovascular Drug Reviews, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert PanelArchives of internal medicine (1960), 1988
- 3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemiaPublished by American Medical Association (AMA) ,1987
- Lipoprotein fractions and receptors: A role for probucol?The American Journal of Cardiology, 1986
- How LDL Receptors Influence Cholesterol and AtherosclerosisScientific American, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- The coronary primary prevention trial: Design and implementationJournal of Chronic Diseases, 1979